Novartis Ag (NVS) Non-cash Items (2009 - 2026)

Novartis Ag has disclosed Non-cash Items across 18 years of filings, most recently posting $3.4 billion for Q2 2026.

• In Q2 2026, Non-cash Items rose 14.32% year-over-year to $3.4 billion; the TTM figure through Jun 2026 stood at $13.8 billion (up 4.59% YoY), while the FY2025 annual figure was $11.2 billion, up 9.74% from the prior year.
• Non-cash Items came in at $3.4 billion for Q2 2026 at Novartis Ag, up from $2.5 billion in the prior quarter.
• In the past five years, Non-cash Items ranged from a high of $5.7 billion in Q4 2025 to a low of $1.8 billion in Q4 2023.
• Average Non-cash Items over 5 years is $3.0 billion, with a median of $2.7 billion recorded in 2023.
• Year-over-year, Non-cash Items plunged 35.01% in 2023 and jumped 173.42% in 2024.
• Over 5 years, Non-cash Items stood at $2.8 billion in 2022, then tumbled by 35.01% to $1.8 billion in 2023, then jumped by 173.42% to $4.9 billion in 2024, then rose by 15.7% to $5.7 billion in 2025, then plunged by 40.4% to $3.4 billion in 2026.
• Per Business Quant data, the three most recent Non-cash Items figures were $3.4 billion in Q2 2026, $2.5 billion in Q1 2026, and $5.7 billion in Q4 2025.